Zimmer Biomet Holdings (ZBH) Receivables (2009 - 2026)

Zimmer Biomet Holdings has reported Receivables for 18 years, with the latest figure at $1.8 billion in Q2 2026.

• On a quarterly basis, Receivables rose 9.82% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 9.82% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 15.11% from the prior year.
• Receivables was $1.8 billion for Q2 2026 at Zimmer Biomet Holdings, up from $1.7 billion in the prior quarter.
• The five-year high for Receivables was $1.8 billion in Q2 2026, with the low at $1.3 billion in Q1 2022.
• Average Receivables over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Receivables retreated 9.74% in 2022, then advanced 15.11% in 2025.
• Over 5 years, Receivables stood at $1.4 billion in 2022, then grew by 4.41% to $1.4 billion in 2023, then gained by 2.66% to $1.5 billion in 2024, then rose by 15.11% to $1.7 billion in 2025, then climbed by 3.82% to $1.8 billion in 2026.
• The last three Receivables figures came in at $1.8 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.7 billion (Q4 2025), per Business Quant data.